Rocky Mountain Cancer Centers, LLP — Aurora, Colorado

Rocky Mountain Cancer Centers, LLP is a clinical research site located in Aurora, Colorado, United States 80012.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Centers, LLP has participated in 11 clinical trials with 7 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Multiple Myeloma, Neoplasms, Colorectal Neoplasms.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Hoffmann-La Roche, Nuvation Bio Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Centers, LLP?

Rocky Mountain Cancer Centers, LLP has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Centers, LLP conducted?

Rocky Mountain Cancer Centers, LLP has 11 clinical trials on record, with 7 currently active. Their work covers HER2-positive Breast Cancer, Multiple Myeloma, Neoplasms, Colorectal Neoplasms.

Is Rocky Mountain Cancer Centers, LLP accredited by Crixeo Health?

Yes — Rocky Mountain Cancer Centers, LLP holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Rocky Mountain Cancer Centers, LLP?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.